Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin

BackgroundVisfatin, adropin, and adiponectin are involved in many changes associated with obesity and metabolic disorders, and may be related to metabolic syndrome and cardiovascular disease. The selection of visfatin, adropin, and adiponectin as biomarkers is based on their significant roles in met...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Anna Maria Cybulska, Daria Schneider-Matyka, Ireneusz Walaszek, Mariusz Panczyk, Dorota Ćwiek, Anna Lubkowska, Elżbieta Grochans, Kamila Rachubińska, Katarzyna Malewicz, Mariusz Chabowski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	adiponectin adropin BMI menopausal women obesity visfatin
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1527567/full